cancer miniseries | GovernmentCIO Media & Research

cancer miniseries

The Surveillance, Epidemiology and End Results Program is kicking off new data initiatives to improve the diagnosis, treatment and outcomes of cancer.
The National Cancer Institute's Center for Global Health is embracing health equity and developing new technologies to advance cancer research and decrease cancer deaths worldwide.
White House Cancer Moonshot Coordinator breaks down a flight path for the future of cancer care transformation.
NCI is studying the relationship between cancer and aging to help survivors lead longer, healthier lives.
NCI is researching the role of telehealth in cancer care and developing best practices for continued integration.
The SBIR center takes a comprehensive approach to fostering underrepresented small businesses.
The Office of Cancer Survivorship takes a comprehensive look at cancer survivor care.
NCI is pushing the "bench to bedside" paradigm to bring medical advances into the clinic.
NCI's ANCHOR study discovered that early treatment of precancerous lesions can cut anal cancer rates by more than half in people with HIV.
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
A recent NCI study explores new immunotherapy treatment for metastatic breast cancer.
The legislation set the foundation for the future of the war against cancer.
NCI’s SEER and CIS programs encourage ongoing engagement to further data sharing goals.
How NCI-designated cancer centers are supporting the national fight against cancer.
Data, communications tech, next-gen DNA sequencing and more have helped accelerate NCI's mission over the past 50 years.
In this episode of our National Cancer Act 50th anniversary miniseries, we dive into how NCI is fighting pediatric cancers.
In this latest episode of the National Cancer Act miniseries, we discuss progress in cancer prevention research and practice.
Making the fight against cancer more equitable requires diversifying cancer research, clinical trials and treatments.
Clinical trials, innovation in research and technology have improved cancer treatment and diagnostics in public health.
We delve into the history of cancer in America and talk to NCI Director Dr. Ned Sharpless on NCI's work the past 50 years.